The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Anaplastic Thyroid Carcinoma: Behavior, Biology, and Therapeutic Approaches
Abstract
Anaplastic thyroid carcinoma (ATC), although exceedingly rare, is the most aggressive solid tumor known. Early studies on the effects of different therapies may be biased by the inclusion of responsive "small cell" ATC patients, which are now known to be mostly lymphoma patients. Local control of disease with surgery and/or external beam radiotherapy (XRT) is of fundamental importance to enhance survival. Ultimately, nearly all ATC patients die from their disease, which is widely metastatic. Development of effective systemic chemotherapy agents would provide the best chance for long-term survival of patients. Early preliminary data suggest that paclitaxel may be helpful, although no agent has yet been identified to result in dramatic improvements in survival. Select patients may benefit from aggressive multimodal therapy, although it is important to provide appropriate palliative care when desired.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1998) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.48.1.6 · Cited by 2,341
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
Fagin, J. A., Matsuo, K., Karmakar, A., Chen, D. L., Tang, S. H., & Koeffler, H. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116168 · Cited by 649
Anaplastic carcinoma of the thyroid: A clinicopathologic study of 121 cases
Venkatesh, Y. S. S., Ordonez, N. G., Schultz, P. N., Hickey, R. C., Goepfert, H., & Samaan, N. A. (1990) · Cancer · doi:10.1002/1097-0142(19900715)66:2<321::aid-cncr2820660221>3.0.co;2-a · Cited by 486
Anaplastic Thyroid Carcinoma: A Study of 70 Cases
Carcangiu, M. L., Steeper, T., Zampi, G., & Rosai, J. (1985) · American Journal of Clinical Pathology · doi:10.1093/ajcp/83.2.135 · Cited by 469
Biology of the multidrug resistance-associated protein, MRP
Loe, D. W., Deeley, R. G., & Cole, S. P. C. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00046-9 · Cited by 367
Aldinger, K. A., Samaan, N. A., Ibanez, M., & Hill, C. S. (1978) · Cancer · doi:10.1002/1097-0142(197806)41:6<2267::aid-cncr2820410627>3.0.co;2-7 · Cited by 364
Anaplastic carcinoma of the thyroid: A 24‐year experience
Tan, R. K. L., Finley, R. K., Driscoll, D., Bakamjian, V. Y., Hicks, W. L., & Shedd, D. P. (1995) · Head & Neck · doi:10.1002/hed.2880170109 · Cited by 237
Chemotherapy of Thyroid Cancer with Adriamycin: Experience with 30 Patients
Gottlieb, J. A., & Hill, C. S. (1974) · New England Journal of Medicine · doi:10.1056/nejm197401242900404 · Cited by 235
Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy
Kim, J. H., & Leeper, R. D. (1987) · Cancer · doi:10.1002/1097-0142(19871115)60:10<2372::aid-cncr2820601004>3.0.co;2-1 · Cited by 232
The pediatric cancer quality of life inventory-32 (PCQL-32): I. Reliability and validity
Varni, J. W., Katz, E. R., Seid, M., Quiggins, D. J. L., & Friedman-Bender, A. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980315)82:6<1146::aid-cncr20>3.0.co;2-5 · Cited by 217
Clinical multidrug resistance in cancer: A multifactorial problem
Lehnert, M. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00069-x · Cited by 176
Stepwise Participation of p53 Gene Mutation During Dedifferentiation of Human Thyroid Carcinomas
Dobashi, Y., Sugimura, H., Sakamoto, A., Mernyei, M., Mori, M., Oyama, T., & Machinami, R. (1994) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199403010-00003 · Cited by 164
p53 Gene Mutations Associated with Anaplastic Transformation of Human Thyroid Carcinomas
Nakamura, T., Yana, I., Kobayashi, T., Shin, E., Karakawa, K., Fujita, S., Miya, A., Mori, T., Nishisho, I., & Takai, S. (1992) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1992.tb02761.x · Cited by 138
Paucicellular Variant of Anaplastic Thyroid Carcinoma:A Mimic of Riedel's Thyroiditis
Wan, S.-K., Chan, J., & Tang, S.-K. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/105.4.388 · Cited by 106
Genetic Alterations in Thyroid Tumor Progression: Association with p53 Gene Mutations
Ito, T., Seyama, T., Mizuno, T., Tsuyama, N., Hayashi, Y., Dohi, K., Nakamura, N., & Akiyama, M. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb00171.x · Cited by 91
Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma
Wong, C. S., Dyk, J. V., & Simpson, W. J. (1991) · Radiotherapy and Oncology · doi:10.1016/0167-8140(91)90105-p · Cited by 88
p53 mutations in all stages of thyroid carcinomas
Zou, M., Shi, Y., & Farid, N. R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.4.1054 · Cited by 75
Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro.
Ain, K. B., & Taylor, K. D. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.5.7909817 · Cited by 64
Self-citationAbe, Y., Ichikawa, Y., Muraki, T., et al. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-1-23 · Cited by 57
Somatostatin Receptor Subtype Expression in Human Thyroid and Thyroid Carcinoma Cell Lines
Ain, K. B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1857 · Cited by 53
Self-citationp53 in a Thyroid Follicular Carcinoma with Foci of Poorly Differentiated and Anaplastic Carcinoma
Matías‐Guiu, X., Villanueva, A., Cuatrecasas, M., Capellá, G., de Leiva, A., & Prat, J. (1996) · Pathology - Research and Practice · doi:10.1016/s0344-0338(96)80159-2 · Cited by 37
Pályi, I., Péter, I., Daubner, D., Vincze, B., & Lõrincz, I. (1993) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899271 · Cited by 33
[Characterization of a human cell line from an anaplastic carcinoma of the thyroid gland].
Gioanni, J., Zanghellini, E., Mazeau, C., Zhang, D., Courdi, A., Farges, M., Lambert, J. C., Duplay, H., & Schneider, M. (1991) · PubMed · Cited by 32
Asakawa, H., Kobayashi, T., Komoike, Y., Yanagawa, T., Takahashi, M. P., Wakasugi, E., Maruyama, H., Tamaki, Y., Matsuzawa, Y., & Monden, M. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855799 · Cited by 20
Boghaert, E. R., Ain, K. B., Taylor, K. D., Greenberg, V. L., Fowler, C. L., & Zimmer, S. G. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00128960 · Cited by 7
Self-citationMODLINGER, R. S., NICOLIS, G. L., Pertsemlidis, D., & Gabrilove, J. L. (1972) · Cancer · doi:10.1002/1097-0142(197209)30:3<848::aid-cncr2820300336>3.0.co;2-2 · Cited by 6
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Haddad, R. I., Bischoff, L., Ball, D., Bernet, V., Blomain, E., Busaidy, N. L., Campbell, M., Dickson, P., Duh, Q.-Y., Ehya, H., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0040 · Cited by 510
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
Molinaro, E., Romei, C., Biagini, A., Sabini, E., Agate, L., Mazzeo, S., Materazzi, G., Sellari-Franceschini, S., Ribechini, A., Torregrossa, L., et al. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.76 · Cited by 483
Anaplastic Thyroid Carcinoma: Biology, Pathogenesis, Prognostic Factors, and Treatment Approaches
Are, C., & Shaha, A. R. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.05.042 · Cited by 440
AACE/AAES MEDICAL/SURGICAL Guidelines for Clinical Practice: Management of Thyroid Carcinoma
Cobin, R. H., Gharib, H., Bergman, D. A., Clark, O. H., Cooper, D. S., Daniels, G. H., Dickey, R. A., Duick, D. S., Garber, J. R., Hay, I. D., et al. (2001) · Endocrine Practice · doi:10.4158/ep.7.3.202 · Cited by 365
Metadata
- Authors
- AIN, K. B.
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 1998-08
- Volume
- 8
- Issue
- 8
- Pages
- 715-726
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W2045070462
- Cited by
- 265
- References
- 26
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.